{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T17:18:15Z","timestamp":1779383895326,"version":"3.53.1"},"reference-count":217,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Steroids have been a foundation of immunosuppressive regimens in solid organ transplantation. However, long-term steroid exposure is associated with a number of adverse effects that increase patient morbidity and mortality, contribute to patient nonadherence, and add significant economic burden. Avoidance of prednisone (AoP) minimizes prednisone-related complications but potentially increases the risk of acute rejection and decreases graft survival. We conducted a narrative review of the risks and benefits of AoP, focusing on randomized studies, large registry reports, and meta-analyses. In low-risk kidney transplant recipients, some, but not all, studies report increased early rejection with AoP; however, steroid-resistant rejection is not increased, and there is no difference between maintenance prednisone and AoP in recipient, graft, and death-censored graft survival. Additionally, AoP and maintenance prednisone have similar outcomes in some \u201chigh-risk\u201d groups (eg, African Americans); for others (eg, high percent reactive antibody), the data are mixed. The benefits of AoP include decreased new-onset diabetes mellitus, a better metabolic profile, improved bone mineral density, decreased fractures, decreased cardiovascular risk, and, in children, improved growth. In pancreas transplantation, historically higher rates of rejection have likely served as a barrier to steroid minimization, although studies suggest that AoP is feasible in low immunologic risk recipients. There are less data on avoidance protocols in liver transplantation, where prednisone dosing has traditionally been lower. Avoidance may have similar or even added benefits to those mentioned previously. There is a need for additional large randomized trials to better define risks and benefits in these situations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005572","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:01:33Z","timestamp":1774263693000},"page":"e809-e825","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prednisone Avoidance After Abdominal Solid Organ Transplantation: A Narrative Review"],"prefix":"10.1097","volume":"110","author":[{"given":"Abraham J.","family":"Matar","sequence":"first","affiliation":[{"name":"Division of Transplantation, Department of Surgery, University of Minnesota Medical School, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Lake","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Kandaswamy","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, University of Minnesota Medical School, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur J.","family":"Matas","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, University of Minnesota Medical School, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"R1-20260521","first-page":"385","article-title":"The reversal of rejection in human renal homograft with subsequent development of homograft tolerance.","volume":"117","author":"Starzl","year":"1963","journal-title":"Surg Gynecol Obstet"},{"key":"R2-20260521","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/bmj.2.5526.1345","article-title":"Further observations on renal transplants in man from cadaveric donors.","volume":"2","author":"Calne","year":"1966","journal-title":"Br Med J"},{"issue":"3 Pt 1","key":"R3-20260521","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1399-0012.1994.tb00245.x","article-title":"Steroid-related complications in the cyclosporine era.","volume":"8","author":"Fryer","year":"1994","journal-title":"Clin Transplant"},{"key":"R4-20260521","first-page":"91","article-title":"Steroid-related complications in pediatric kidney transplant recipients in the cyclosporine era.","volume":"26","author":"Fryer","year":"1994","journal-title":"Transplant Proc"},{"key":"R5-20260521","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/ajt.12313","article-title":"Association between steroid dosage and death with a functioning graft after kidney transplantation.","volume":"13","author":"Opelz","year":"2013","journal-title":"Am J Transplant"},{"key":"R6-20260521","doi-asserted-by":"crossref","first-page":"101023","DOI":"10.1080\/17425255.2018.1530214","article-title":"Glucocorticoids use in kidney transplant setting.","volume":"14","author":"De Lucena","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R7-20260521","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1399-0012.2003.00034.x","article-title":"Renal transplant recipient attitudes toward steroid use and steroid withdrawal.","volume":"17","author":"Prasad","year":"2003","journal-title":"Clin Transplant"},{"key":"R8-20260521","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0272-6386(99)70414-2","article-title":"The incidence and long-term cost of steroid-related side effects after renal transplantation.","volume":"33","author":"Veenstra","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R9-20260521","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/00365591003649219","article-title":"Cost-benefit of steroid avoidance in renal transplant patients: a prospective randomized study.","volume":"44","author":"Gheith","year":"2010","journal-title":"Scand J Urol Nephrol"},{"key":"R10-20260521","doi-asserted-by":"crossref","first-page":"100474","DOI":"10.1016\/j.xkme.2022.100474","article-title":"Kidney Transplantation, Immunosuppression and the Risk of Fracture: Clinical and Economic Implications.","volume":"4","author":"Kuppachi","year":"2022","journal-title":"Kidney Med"},{"key":"R11-20260521","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1681\/ASN.V11101910","article-title":"A meta-analysis of immunosuppression withdrawal trials in renal transplantation.","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R12-20260521","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1681\/ASN.V461300","article-title":"Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis.","volume":"4","author":"Hricik","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"R13-20260521","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1097\/01.TP.0000140969.43761.1F","article-title":"Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials.","volume":"78","author":"Pascual","year":"2004","journal-title":"Transplantation"},{"key":"R14-20260521","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/TP.0b013e3181e58912","article-title":"A systematic review on steroid withdrawal between 3 and 6 months after kidney transplantation.","volume":"90","author":"Pascual","year":"2010","journal-title":"Transplantation"},{"key":"R15-20260521","first-page":"CD005632","article-title":"Steroid avoidance or withdrawal for kidney transplant recipients.","volume":"1","author":"Pascual","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"R16-20260521","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/ndt\/gfr374","article-title":"Very early steroid withdrawal or complete avoidance for kidney transplant recipients: a systematic review.","volume":"27","author":"Pascual","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R17-20260521","first-page":"CD005632","article-title":"Steroid avoidance or withdrawal for kidney transplant recipients.","volume":"2016","author":"Haller","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R18-20260521","first-page":"2669","article-title":"Cyclosporine therapy with and without steroids in cadaver kidney transplantation\u2014a prospective randomized one-center study.","volume":"17","author":"Albert","year":"1985","journal-title":"Transplant Proc"},{"key":"R19-20260521","first-page":"1187","article-title":"Cyclosporine alone or in combination with prednisone in cadaveric renal transplantation.","volume":"16","author":"Thiel","year":"1984","journal-title":"Transplant Proc"},{"key":"R20-20260521","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0022-3476(87)80050-1","article-title":"Renal transplantation without steroids.","volume":"111","author":"Salaman","year":"1987","journal-title":"J Pediatrics"},{"key":"R21-20260521","first-page":"1935","article-title":"A controlled trial of triple therapy in renal transplantation.","volume":"43","author":"Salaman","year":"1987","journal-title":"Transplant Proc"},{"key":"R22-20260521","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00007890-198802000-00015","article-title":"Withdrawal of steroid immunosuppression in renal transplant recipients.","volume":"45","author":"Stratta","year":"1988","journal-title":"Transplantation"},{"key":"R23-20260521","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00007890-198704000-00010","article-title":"A controlled trial of steroids in cyclosporine-treated renal transplant recipients.","volume":"43","author":"Griffin","year":"1987","journal-title":"Transplantation"},{"key":"R24-20260521","first-page":"1581","article-title":"Cadaver renal transplantation without maintenance steroids.","volume":"21","author":"Johnson","year":"1989","journal-title":"Transplant Proc"},{"key":"R25-20260521","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1399-0012.1987.tb00966.x","article-title":"Cyclosporine alone or combined with steroids in the treatment of cadaveric renal transplant recipients.","volume":"1","author":"DeVecchi","year":"1987","journal-title":"Clin Transplant"},{"key":"R26-20260521","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1681\/ASN.V84638","article-title":"A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation. Italian Multicentre Study Group for Renal Transplantation (SIMTRe).","volume":"8","author":"Ponticelli","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R27-20260521","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1681\/ASN.V12102163","article-title":"Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation.","volume":"12","author":"Montagnino","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R28-20260521","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00007890-199107000-00011","article-title":"A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation.","volume":"52","author":"Tarantino","year":"1991","journal-title":"Transplantation"},{"key":"R29-20260521","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1097\/00007890-199912270-00009","article-title":"Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil\u2014a prospective randomized study. Steroid Withdrawal Study Group.","volume":"68","author":"Ahsan","year":"1999","journal-title":"Transplantation"},{"key":"R30-20260521","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/00007890-200011150-00015","article-title":"Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection.","volume":"70","author":"Vanrenterghem","year":"2000","journal-title":"Transplantation"},{"key":"R31-20260521","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(05)64455-8","article-title":"Steroid-free immunosuppression in renal transplantation.","volume":"348","author":"Birkeland","year":"1996","journal-title":"Lancet"},{"key":"R32-20260521","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/00007890-200104270-00013","article-title":"Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients.","volume":"71","author":"Birkeland","year":"2001","journal-title":"Transplantation"},{"key":"R33-20260521","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0041-1345(00)02308-3","article-title":"Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation.","volume":"33","author":"Vincenti","year":"2001","journal-title":"Transplant Proc"},{"key":"R34-20260521","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/00007890-200109150-00018","article-title":"A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients.","volume":"72","author":"Cole","year":"2001","journal-title":"Transplantation"},{"key":"R35-20260521","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1097\/00007890-200004271-00085","article-title":"Kidney transplantation without prednisone.","volume":"69","author":"Kaufman","year":"2000","journal-title":"Transplantation"},{"key":"R36-20260521","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1097\/00007890-200004271-00086","article-title":"Renal transplantation without steroids\u2014one year results of a multicentre Canadian pilot study.","volume":"69","author":"Landsberg","year":"2000","journal-title":"Transplantation"},{"key":"R37-20260521","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1034\/j.1600-6143.2001.001003278.x","article-title":"Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study.","volume":"1","author":"Matas","year":"2001","journal-title":"Am J Transplant"},{"key":"R38-20260521","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1097\/00007890-200004271-00088","article-title":"Early corticosteroid cessation at one week following kidney transplant under tacrolimus and mycophenolate mofetil (MMF) immunosuppression, three-year follow-up.","volume":"69","author":"Buell","year":"2000","journal-title":"Transplantation"},{"key":"R39-20260521","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0041-1345(98)00281-4","article-title":"Corticosteroid cessation 1 week following renal transplantation using tacrolimus\/mycophenolate mofetil based immunosuppression.","volume":"30","author":"Grewal","year":"1998","journal-title":"Transplant Proc"},{"key":"R40-20260521","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-6143.2004.00655.x","article-title":"A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus.","volume":"5","author":"Woodle","year":"2005","journal-title":"Am J Transplant"},{"key":"R41-20260521","first-page":"645","article-title":"Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts.","volume":"147","author":"Sinclair","year":"1992","journal-title":"CMAJ"},{"key":"R42-20260521","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1034\/j.1600-6143.2003.00005.x","article-title":"Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil.","volume":"3","author":"Vincenti","year":"2003","journal-title":"Am J Transplant"},{"key":"R43-20260521","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-6143.2007.02057.x","article-title":"A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients.","volume":"8","author":"Vincenti","year":"2008","journal-title":"Am J Transplant"},{"key":"R44-20260521","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-2277.2009.00971.x","article-title":"Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti-T-lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction.","volume":"23","author":"Cantarovich","year":"2010","journal-title":"Transpl Int"},{"key":"R45-20260521","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1111\/ajt.12866","article-title":"Early corticosteroid avoidance in kidney transplant recipients receiving ATG-F induction: 5-year actual results of a prospective and randomized study.","volume":"14","author":"Cantarovich","year":"2014","journal-title":"Am J Transplant"},{"key":"R46-20260521","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/TP.0b013e3181949d2e","article-title":"No occurrence of de novo HLA antibodies in recipients with early corticosteroid withdrawal in a 5-year prospective randomized study.","volume":"87","author":"Delgado","year":"2009","journal-title":"Transplantation"},{"key":"R47-20260521","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.surg.2004.10.013","article-title":"Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety.","volume":"137","author":"Laftavi","year":"2005","journal-title":"Surgery"},{"key":"R48-20260521","first-page":"673","article-title":"Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: a prospective, randomized, controlled study.","volume":"5","author":"Nematalla","year":"2007","journal-title":"Exp Clin Transplant"},{"key":"R49-20260521","first-page":"216","article-title":"Early steroid withdrawal in a renal transplant cohort treated with tacrolimus, mycophenolate mofetil and basiliximab.","volume":"34","author":"Andrade-Sierra","year":"2014","journal-title":"Nefrologia"},{"key":"R50-20260521","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1097\/TXD.0000000000000794","article-title":"Early steroid withdrawal compared with standard immunosuppression in kidney transplantation\u2014interim analysis of the Amsterdam-Leiden-Groningen randomized controlled trial.","volume":"4","author":"van Sandwijk","year":"2018","journal-title":"Transplant Direct"},{"key":"R51-20260521","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/TP.0000000000004776","article-title":"Comparison of 2 Immunosuppression Minimization Strategies in Kidney Transplantation: The ALLEGRO Trial.","volume":"108","author":"van den Born","year":"2024","journal-title":"Transplantation"},{"key":"R52-20260521","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.transproceed.2014.11.063","article-title":"Long-term study of steroid avoidance in renal transplant patients: a single-center experience.","volume":"47","author":"Nagib","year":"2015","journal-title":"Transplant Proc"},{"key":"R53-20260521","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/SLA.0b013e318187d1da","article-title":"A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.","volume":"248","author":"Woodle","year":"2008","journal-title":"Ann Surg"},{"key":"R54-20260521","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jamasurg.2020.6929","article-title":"Early corticosteroid cessation vs long-term corticosteroid therapy in kidney transplant recipients: long-term outcomes of a randomized clinical trial.","volume":"156","author":"Woodle","year":"2021","journal-title":"JAMA Surg"},{"key":"R55-20260521","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1600-6143.2004.00419.x","article-title":"Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study.","volume":"4","author":"ter Meulen","year":"2004","journal-title":"Am J Transplant"},{"key":"R56-20260521","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.TP.0000154915.20524.0A","article-title":"Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation.","volume":"79","author":"Rostaing","year":"2005","journal-title":"Transplantation"},{"key":"R57-20260521","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1097\/01.tp.0000188300.26762.74","article-title":"Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus\/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study.","volume":"80","author":"V\u00edtko","year":"2005","journal-title":"Transplantation"},{"key":"R58-20260521","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/TP.0b013e31825c1d6c","article-title":"Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial.","volume":"94","author":"Kr\u00e4mer","year":"2012","journal-title":"Transplantation"},{"key":"R59-20260521","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1399-0012.2009.01162.x","article-title":"Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results.","volume":"24","author":"Kr\u00e4mer","year":"2010","journal-title":"Clin Transplant"},{"key":"R60-20260521","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/00007890-200212270-00011","article-title":"Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study.","volume":"74","author":"Boots","year":"2002","journal-title":"Transplantation"},{"key":"R61-20260521","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.nefro.2016.03.019","article-title":"Lymphocyte-depleting induction and steroid minimization after kidney transplantation: a review.","volume":"36","author":"Naesens","year":"2016","journal-title":"Nefrologia"},{"key":"R62-20260521","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/S0140-6736(16)32187-0","article-title":"Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.","volume":"388","author":"Thomusch","year":"2016","journal-title":"Lancet"},{"key":"R63-20260521","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ndt\/gfad130","article-title":"Excellent efficacy and beneficial safety during observational 5-year follow-up of rapid steroid withdrawal after renal transplantation (Harmony FU Study).","volume":"39","author":"Stumpf","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"R64-20260521","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1009546","article-title":"Alemtuzumab induction in renal transplantation.","volume":"364","author":"Hanaway","year":"2011","journal-title":"N Engl J Med"},{"key":"R65-20260521","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/j.1600-6143.2008.02273.x","article-title":"Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial.","volume":"8","author":"Margreiter","year":"2008","journal-title":"Am J Transplant"},{"key":"R66-20260521","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/TP.0b013e3182a64db9","article-title":"Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trial.","volume":"96","author":"Welberry Smith","year":"2013","journal-title":"Transplantation"},{"key":"R67-20260521","first-page":"1684","article-title":"Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomized trial.","volume":"384","author":"Haynes","year":"2014","journal-title":"Clin Trial"},{"key":"R68-20260521","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/TP.0b013e3182384b21","article-title":"Randomized trial of dual antibody induction therapy with steroid avoidance in renal transplantation.","volume":"92","author":"Ciancio","year":"2011","journal-title":"Transplantation"},{"key":"R69-20260521","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/01.TP.0000441089.39840.66","article-title":"3rd: Randomized trial of three induction antibodies in kidney transplantation: Long-term results.","volume":"97","author":"Ciancio","year":"2014","journal-title":"Transplantation"},{"key":"R70-20260521","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-6143.2010.03338.x","article-title":"Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients.","volume":"11","author":"Ferguson","year":"2011","journal-title":"Am J Transplant"},{"key":"R71-20260521","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/ajt.15688","article-title":"Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: a prospective, randomized multicenter trial.","volume":"20","author":"Woodle","year":"2020","journal-title":"Am J Transplant"},{"key":"R72-20260521","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2215\/CJN.13100820","article-title":"Belatacept for simultaneous calcineurin inhibitor and chronic corticosteroid immunosuppression avoidance: two-year results of a prospective, randomized multicenter trial.","volume":"16","author":"Kaufman","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"R73-20260521","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/01.tp.0000232688.76018.19","article-title":"High rejection rate during calcineurin inhibitor-free and early steroid withdrawal immunosuppression in renal transplantation.","volume":"82","author":"Gelens","year":"2006","journal-title":"Transplantation"},{"key":"R74-20260521","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1111\/ajt.14377","article-title":"Lesson\u2019s learned: early termination of a randomized trial of calcineurin inhibitor and corticosteroid avoidance using belatacept.","volume":"17","author":"Newell","year":"2017","journal-title":"Am J Transplant"},{"key":"R75-20260521","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1111\/ajt.16152","article-title":"Avoidance of CNI and steroids using belatacept-results of the clinical trials in organ transplantation 16 trial.","volume":"20","author":"Mannon","year":"2020","journal-title":"Am J Transplant"},{"key":"R76-20260521","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1016\/j.transproceed.2012.07.142","article-title":"High incidence of rejection episodes and poor tolerance of sirolimus in a protocol with early steroid withdrawal and calcineurin inhibitor-free maintenance therapy in renal transplantation: experiences of a randomized prospective single-center study.","volume":"44","author":"Burkhalter","year":"2012","journal-title":"Transplant Proc"},{"key":"R77-20260521","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/TP.0b013e31822805d7","article-title":"Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal.","volume":"92","author":"Heilman","year":"2011","journal-title":"Transplantation"},{"key":"R78-20260521","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1600-6143.2005.00885.x","article-title":"A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients\u2014an interim analysis.","volume":"5","author":"Kandaswamy","year":"2005","journal-title":"Am J Transplant"},{"key":"R79-20260521","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/ajt.12166","article-title":"Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation.","volume":"13","author":"Suszynski","year":"2013","journal-title":"Am J Transplant"},{"key":"R80-20260521","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/j.1600-6143.2006.01340.x","article-title":"Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF.","volume":"6","author":"Gallon","year":"2006","journal-title":"Am J Transplant"},{"key":"R81-20260521","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1097\/TP.0000000000001453","article-title":"Incidence of posttransplantation diabetes mellitus in de novo kidney transplant recipients receiving prolonged-release tacrolimus-based immunosuppression with 2 different corticosteroid minimization strategies: ADVANCE, a randomized controlled trial.","volume":"101","author":"Mourad","year":"2017","journal-title":"Transplantation"},{"key":"R82-20260521","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ekir.2021.11.028","article-title":"A randomized controlled trial on safety of steroid avoidance in immunologically low-risk kidney transplant recipients.","volume":"7","author":"Ekberg","year":"2021","journal-title":"Kidney Int Rep"},{"key":"R83-20260521","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/tri.13530","article-title":"Rapid discontinuation of prednisone in kidney transplant recipients from at-risk subgroups: an OPTN\/SRTR analysis.","volume":"33","author":"Vock","year":"2020","journal-title":"Transpl Int"},{"key":"R84-20260521","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/ndt\/gfae218","article-title":"Early steroid withdrawal and kidney transplant outcomes in first-transplant and retransplant recipients.","volume":"40","author":"Bae","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"R85-20260521","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2215\/CJN.00910121","article-title":"Recurrence of IgA nephropathy after kidney transplantation in adults.","volume":"16","author":"Uffing","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"R86-20260521","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/tri.13075","article-title":"Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: a retrospective analysis of the UNOS\/OPTN data base.","volume":"31","author":"Leeaphorn","year":"2018","journal-title":"Transpl Int"},{"key":"R87-20260521","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/j.1600-6143.2011.03667.x","article-title":"Steroids and recurrent IgA nephropathy after kidney transplantation.","volume":"11","author":"Clayton","year":"2011","journal-title":"Am J Transplant"},{"key":"R88-20260521","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1600-6143.2009.02554.x","article-title":"Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis.","volume":"9","author":"Mulay","year":"2009","journal-title":"Am J Transplant"},{"key":"R89-20260521","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.kint.2019.02.041","article-title":"A propensity score matched analysis shows no adverse effect of early steroid withdrawal in non-diabetic kidney transplant recipients with and without glomerulonephritis.","volume":"96","author":"Barbour","year":"2019","journal-title":"Kidney Int"},{"key":"R90-20260521","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2215\/CJN.04880516","article-title":"A comparative effectiveness analysis of early steroid withdrawal in black kidney transplant recipients.","volume":"12","author":"Taber","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"R91-20260521","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1600-6143.2007.02099.x","article-title":"Long-term outcome of early steroid withdrawal after kidney transplantation in African American recipients monitored by surveillance biopsy.","volume":"8","author":"Kumar","year":"2008","journal-title":"Am J Transplant"},{"key":"R92-20260521","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.transproceed.2004.12.071","article-title":"African American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression.","volume":"37","author":"Boardman","year":"2005","journal-title":"Transplant Proc"},{"key":"R93-20260521","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.transproceed.2010.02.081","article-title":"Influence of African-American ethnicity on acute rejection after early steroid withdrawal in primary kidney transplant recipients.","volume":"42","author":"Padiyar","year":"2010","journal-title":"Transplant Proc"},{"key":"R94-20260521","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1111\/j.1600-6143.2005.00984.x","article-title":"Avoidance of chronic steroid therapy in African American kidney transplant recipients monitored by surveillance biopsy: 1-year results.","volume":"5","author":"Anil Kumar","year":"2005","journal-title":"Am J Transplant"},{"key":"R95-20260521","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4236\/ijcm.2016.73021","article-title":"Impact of maintenance steroids versus rapid steroid withdrawal in African-American kidney transplant recipients: comparison of two urban centers.","volume":"7","author":"Chon","year":"2016","journal-title":"Int J Clin Med"},{"key":"R96-20260521","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/kjm2.12064","article-title":"Steroid withdrawal or avoidance is safe in high-risk kidney transplants: a systematic review and meta-analysis.","volume":"35","author":"Song","year":"2019","journal-title":"Kaohsiung J Med Sci"},{"key":"R97-20260521","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/TP.0000000000003777","article-title":"Panel-reactive antibody and the association of early steroid withdrawal with kidney transplant outcomes.","volume":"106","author":"Bae","year":"2022","journal-title":"Transplantation"},{"key":"R98-20260521","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.transproceed.2024.10.037","article-title":"Early steroid withdrawal versus steroid maintenance in adults older than 65 receiving second kidney transplants.","volume":"56","author":"Ca\u00f1izares","year":"2024","journal-title":"Transplant Proc"},{"key":"R99-20260521","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00007890-201407151-00446","article-title":"Comparative effectiveness of triple immunosuppressive therapy versus steroid avoidance or early withdrawal among kidney transplant recipients over age 65.","volume":"98","author":"Harris","year":"2014","journal-title":"Transplantation"},{"key":"R100-20260521","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s40266-024-01147-4","article-title":"Assessing long-term adverse outcomes in older kidney transplant recipients: a propensity score-matched comparison of early steroid withdrawal versus continuous steroid immunosuppression using a large real-world database.","volume":"41","author":"Johnson","year":"2024","journal-title":"Drugs Aging"},{"key":"R101-20260521","doi-asserted-by":"crossref","first-page":"e13668","DOI":"10.1111\/ctr.13668","article-title":"Prednisone-free maintenance immunosuppression in obese kidney transplant recipients.","volume":"33","author":"Matas","year":"2019","journal-title":"Clin Transplant"},{"key":"R102-20260521","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/ajt.16195","article-title":"Early steroid withdrawal in HIV-infected kidney transplant recipients: utilization and outcomes.","volume":"21","author":"Werbel","year":"2021","journal-title":"Am J Transplant"},{"key":"R103-20260521","first-page":"287.41","article-title":"Outcomes of early steroid withdrawal in recipients of deceased-donor expanded criteria kidney transplants in the era of induction therapy.","volume":"14","author":"Hussain","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"R104-20260521","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5500\/wjt.v5.i3.102","article-title":"Role of steroid maintenance in sensitized kidney transplant recipients.","volume":"5","author":"Sureshkumar","year":"2015","journal-title":"World J Transplant"},{"key":"R105-20260521","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4103\/0971-4065.120328","article-title":"Influence of steroid maintenance on the outcomes in deceased donor kidney transplant recipients experiencing delayed graft function.","volume":"23","author":"Tangirala","year":"2013","journal-title":"Indian J Nephrol"},{"key":"R106-20260521","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2019040416","article-title":"Early steroid withdrawal in deceased-donor kidney transplant recipients with delayed graft function.","volume":"31","author":"Bae","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"R107-20260521","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/TP.0b013e3182472898","article-title":"Influence of induction modality on the outcome of deceased donor kidney transplant recipients discharged on steroid-free maintenance immunosuppression.","volume":"93","author":"Kumar","year":"2012","journal-title":"Transplantation"},{"key":"R108-20260521","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2215\/CJN.13171215","article-title":"Acute rejection rates and graft outcomes according to induction regimen among recipients of kidneys from deceased donors treated with tacrolimus and mycophenolate.","volume":"11","author":"Tanriover","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"R109-20260521","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2215\/CJN.08710814","article-title":"Induction therapies in live donor kidney transplantation on tacrolimus and mycophenolate with or without steroid maintenance.","volume":"10","author":"Tanriover","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R110-20260521","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1097\/TP.0000000000003547","article-title":"Immunosuppression regimen use and outcomes in older and younger adult kidney transplant recipients: a national registry analysis.","volume":"105","author":"Lentine","year":"2021","journal-title":"Transplantation"},{"key":"R111-20260521","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/TP.0b013e318203c25f","article-title":"New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression.","volume":"91","author":"Luan","year":"2011","journal-title":"Transplantation"},{"key":"R112-20260521","doi-asserted-by":"crossref","first-page":"e1260","DOI":"10.1097\/TXD.0000000000001260","article-title":"Effect of early steroid withdrawal on posttransplant diabetes among kidney transplant recipients differs by recipient age.","volume":"8","author":"Ahn","year":"2021","journal-title":"Transplant Direct"},{"key":"R113-20260521","doi-asserted-by":"crossref","first-page":"100377","DOI":"10.1016\/j.xkme.2021.08.012","article-title":"Posttransplant diabetes mellitus and immunosuppression selection in older and obese kidney recipients.","volume":"4","author":"Axelrod","year":"2021","journal-title":"Kidney Med"},{"key":"R114-20260521","doi-asserted-by":"crossref","first-page":"100856","DOI":"10.1016\/j.trre.2024.100856","article-title":"Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: a systematic review and meta-analysis.","volume":"38","author":"Oliveras","year":"2024","journal-title":"Transplant Rev"},{"key":"R115-20260521","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/ndt\/gfx193","article-title":"Graft survival of pediatric kidney transplant recipients selected for de novo steroid avoidance\u2014a propensity score-matched study.","volume":"32","author":"Nehus","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"R116-20260521","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-6143.2008.02442.x","article-title":"Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression.","volume":"9","author":"Luan","year":"2009","journal-title":"Am J Transplant"},{"key":"R117-20260521","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2215\/CJN.03410321","article-title":"Bone and mineral disease in kidney transplant recipients.","volume":"17","author":"Khairallah","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"R118-20260521","doi-asserted-by":"crossref","first-page":"1759720X20953357","DOI":"10.1177\/1759720X20953357","article-title":"Early steroid withdrawal has a positive effect on bone in kidney transplant recipients: a propensity score study with inverse probability-of-treatment weighting.","volume":"12","author":"Batteux","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R119-20260521","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00198-018-4383-2","article-title":"Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.","volume":"29","author":"Segaud","year":"2018","journal-title":"Osteoporos Int"},{"key":"R120-20260521","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/ndt\/gfy306","article-title":"Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocol.","volume":"35","author":"Evenepoel","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"R121-20260521","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1600-6143.2011.03872.x","article-title":"Reduced fracture risk with early corticosteroid withdrawal after kidney transplant.","volume":"12","author":"Nikkel","year":"2012","journal-title":"Am J Transplant"},{"key":"R122-20260521","doi-asserted-by":"crossref","first-page":"e13813","DOI":"10.1111\/ctr.13813","article-title":"Economic impacts of alternative kidney transplant immunosuppression: a national cohort study.","volume":"34","author":"Axelrod","year":"2020","journal-title":"Clin Transplant"},{"key":"R123-20260521","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000347024","article-title":"Steroid withdrawal in pediatric kidney transplant allows better growth, lipids and body composition: a randomized controlled trial.","volume":"79","author":"Mericq","year":"2013","journal-title":"Horm Res Paediatr"},{"key":"R124-20260521","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1600-6143.2010.03047.x","article-title":"A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study.","volume":"10","author":"Grenda","year":"2010","journal-title":"Am J Transplant"},{"key":"R125-20260521","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/TP.0000000000000498","article-title":"Corticosteroid-free kidney transplantation improves growth: 2-year follow-up of the TWIST randomized controlled trial.","volume":"99","author":"Webb","year":"2015","journal-title":"Transplantation"},{"key":"R126-20260521","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/j.1600-6143.2012.04145.x","article-title":"Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up.","volume":"12","author":"Sarwal","year":"2012","journal-title":"Am J Transplant"},{"key":"R127-20260521","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1111\/j.1600-6143.2012.04144.x","article-title":"Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantation.","volume":"12","author":"Naesens","year":"2012","journal-title":"Am J Transplant"},{"key":"R128-20260521","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s00467-011-1934-6","article-title":"Early steroid withdrawal in pediatric renal transplant: five years of follow-up.","volume":"26","author":"Delucchi","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"R129-20260521","doi-asserted-by":"crossref","first-page":"e14096","DOI":"10.1111\/petr.14096","article-title":"Long-term outcome of early steroid withdrawal in pediatric renal transplantation.","volume":"25","author":"Gajardo","year":"2021","journal-title":"Pediatr Transplant"},{"key":"R130-20260521","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1600-6143.2009.02640.x","article-title":"Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits.","volume":"9","author":"Li","year":"2009","journal-title":"Am J Transplant"},{"key":"R131-20260521","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/petr.12633","article-title":"Improved cardiovascular risk factors in pediatric renal transplant recipients on steroid avoidance immunosuppression: a study of the Midwest Pediatric Nephrology Consortium.","volume":"20","author":"Weaver","year":"2016","journal-title":"Pediatr Transplant"},{"key":"R132-20260521","doi-asserted-by":"crossref","first-page":"e14189","DOI":"10.1111\/petr.14189","article-title":"Steroid avoidance\/withdrawal and maintenance immunosuppression in pediatric kidney transplantation.","volume":"26","author":"Kizilbash","year":"2022","journal-title":"Pediatr Transplant"},{"key":"R133-20260521","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/TP.0000000000001320","article-title":"Corticosteroid use and growth after pediatric solid organ transplantation: a systematic review and meta-analysis.","volume":"101","author":"Tsampalieros","year":"2017","journal-title":"Transplantation"},{"key":"R134-20260521","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1399-3046.2005.00319.x","article-title":"Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.","volume":"9","author":"Oberholzer","year":"2005","journal-title":"Pediatr Transplant"},{"key":"R135-20260521","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/TP.0b013e3181ac6833","article-title":"Pediatric kidney transplantation using a novel protocol of rapid (6-day) discontinuation of prednisone: 2-year results.","volume":"88","author":"Chavers","year":"2009","journal-title":"Transplantation"},{"key":"R136-20260521","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1399-3046.2009.01254.x","article-title":"Extended experience with a steroid minimization immunosuppression protocol in pediatric renal transplant recipients.","volume":"14","author":"Lau","year":"2010","journal-title":"Pediatr Transplant"},{"key":"R137-20260521","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1399-3046.2009.01135.x","article-title":"Steroid avoidance using sirolimus and cyclosporine in pediatric renal transplantation: one year analysis.","volume":"14","author":"Iorember","year":"2010","journal-title":"Pediatr Transplant"},{"key":"R138-20260521","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/petr.12374","article-title":"Single-center experience in pediatric renal transplantation using thymoglobulin induction and steroid minimization.","volume":"18","author":"Warejko","year":"2014","journal-title":"Pediatr Transplant"},{"key":"R139-20260521","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/petr.12186","article-title":"Long-term experience of steroid-free pediatric renal transplantation: effects on graft function, body mass index, and longitudinal growth.","volume":"18","author":"Wittenhagen","year":"2014","journal-title":"Pediatr Transplant"},{"key":"R140-20260521","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1600-6143.2007.01883.x","article-title":"Steroid avoidance regimens: a comparison of outcomes with maintenance steroids versus continued steroid avoidance in recipients having an acute rejection episode.","volume":"7","author":"Humar","year":"2007","journal-title":"Am J Transplant"},{"key":"R141-20260521","doi-asserted-by":"crossref","first-page":"e14176","DOI":"10.1111\/ctr.14176","article-title":"Inconsistencies in the association of clinical factors with the choice of early steroid withdrawal across kidney transplant centers: a national registry study.","volume":"35","author":"Bae","year":"2021","journal-title":"Clin Transplant"},{"key":"R142-20260521","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1111\/ajt.13270","article-title":"Clinical practice of steroid avoidance in pediatric kidney transplantation.","volume":"15","author":"Nehus","year":"2015","journal-title":"Am J Transplant"},{"key":"R143-20260521","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1111\/j.1600-6143.2005.01051.x","article-title":"Prednisone-free maintenance immunosuppression\u2014a 5-year experience.","volume":"5","author":"Matas","year":"2005","journal-title":"Am J Transplant"},{"key":"R144-20260521","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/BF02405356","article-title":"Bone loss after glucocorticoid therapy.","volume":"36","author":"Lo Cascio","year":"1984","journal-title":"Calcif Tissue Int"},{"key":"R145-20260521","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-119-10-199311150-00001","article-title":"Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis: a randomized, controlled study.","volume":"119","author":"Laan","year":"1993","journal-title":"Ann Intern Med"},{"key":"R146-20260521","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","article-title":"Oral corticosteroids and fracture risk: relationship to daily and cumulative doses.","volume":"39","author":"Van Staa","year":"2000","journal-title":"Rheumatology"},{"key":"R147-20260521","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.1780240705","article-title":"Bone loss in adults receiving alternate day glucocorticoid therapy: a comparison with daily therapy.","volume":"24","author":"Gluck","year":"1981","journal-title":"Arthritis Rheum"},{"key":"R148-20260521","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/thorax.56.4.279","article-title":"Adverse effects of oral corticosteroids in relation to dose in patients with lung disease.","volume":"56","author":"Walsh","year":"2001","journal-title":"Thorax"},{"key":"R149-20260521","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2796.2005.01467.x","article-title":"Fracture risk associated with systemic and topical corticosteroids.","volume":"257","author":"Vestergaard","year":"2005","journal-title":"J Intern Med"},{"key":"R150-20260521","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/art.21568","article-title":"Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.","volume":"54","author":"Wolfe","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R151-20260521","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/art.23811","article-title":"The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis.","volume":"58","author":"Wolfe","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R152-20260521","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/art.21984","article-title":"Population-based assessment of adverse events associated with long-term glucocorticoid use.","volume":"55","author":"Curtis","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R153-20260521","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF00542348","article-title":"Corticosteroid induced bone loss: a longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography.","volume":"25","author":"Ruegsegger","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"key":"R154-20260521","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3949\/ccjm.87a.19039","article-title":"Glucocorticoid-induced osteoporosis: insights for the clinician.","volume":"87","author":"Hayat","year":"2020","journal-title":"Cleve Clin J Med"},{"key":"R155-20260521","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1359\/JBMR.041125","article-title":"Effects of low-dose prednisone on bone metabolism.","volume":"20","author":"Ton","year":"2005","journal-title":"J Bone Miner Res"},{"key":"R156-20260521","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/13696998.2025.2477877","article-title":"Adverse consequences of systemic corticosteroids use among a broad population of US adults with asthma: a real-world analysis.","volume":"28","author":"Wu","year":"2025","journal-title":"J Med Econ"},{"key":"R157-20260521","first-page":"2222","article-title":"Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo-controlled trial.","volume":"9","author":"McKenzie","year":"2000","journal-title":"J Rheumatol"},{"key":"R158-20260521","first-page":"471","article-title":"Quantifying cutaneous adverse effects of systemic glucocorticoids in patients with rheumatoid arthritis: a cross-sectional cohort study.","volume":"35","author":"Amann","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"R159-20260521","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/ard.2008.092163","article-title":"Dose-related patterns of glucocorticoid-induced side effects.","volume":"68","author":"Huscher","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R160-20260521","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1442-9071.1994.tb01696.x","article-title":"Ocular complications in renal transplant patients.","volume":"22","author":"Mataunami","year":"1994","journal-title":"Aust N Z J Ophthalmol"},{"key":"R161-20260521","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM199108223250804","article-title":"Rapid loss of vertebral mineral density after renal transplantation.","volume":"325","author":"Julian","year":"1991","journal-title":"N Engl J Med"},{"key":"R162-20260521","first-page":"1186","article-title":"Factors influencing vertebral bone density after renal transplantation.","volume":"58","author":"Wolpaw","year":"1994","journal-title":"Transplantation"},{"key":"R163-20260521","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1432-2277.2003.tb00304.x","article-title":"Weight changes after renal transplantation: a comparison between patients on 5-mg maintenance steroid therapy and those on steroid-free immunosuppressive therapy.","volume":"16","author":"van den Ham","year":"2003","journal-title":"Transpl Int"},{"key":"R164-20260521","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e3181c518cc","article-title":"Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis.","volume":"89","author":"Knight","year":"2010","journal-title":"Transplantation"},{"key":"R165-20260521","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/TP.0b013e318160254f","article-title":"Risk factors for cardiovascular events after successful renal transplantation.","volume":"85","author":"Vanrenterghem","year":"2008","journal-title":"Transplantation"},{"key":"R166-20260521","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1097\/TP.0000000000001284","article-title":"Strategic use of epitope matching to improve outcomes.","volume":"100","author":"Wiebe","year":"2016","journal-title":"Transplantation"},{"key":"R167-20260521","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.kint.2021.06.026","article-title":"Significance of HLA-DQ in kidney trans- plantation: time to reevaluate human leukocyte antigen-matching priorities to improve transplant outcomes? An expert review and recommendations.","volume":"100","author":"Tambur","year":"2021","journal-title":"Kidney Int"},{"key":"R168-20260521","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/ajt.15177","article-title":"HLA-DR\/DQ molecular mismatch: a prognostic biomarker for primary alloimmunity.","volume":"19","author":"Wiebe","year":"2019","journal-title":"Am J Transplant"},{"key":"R169-20260521","doi-asserted-by":"crossref","first-page":"1548934","DOI":"10.3389\/fimmu.2025.1548934","article-title":"Advancing risk stratification in kidney transplantation: integrating HLA-derived T-cell epitope and B-cell epitope matching algorithms for enhanced predictive accuracy of HLA compatibility.","volume":"16","author":"Niemann","year":"2025","journal-title":"Front Immunol"},{"key":"R170-20260521","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00041552-199805000-00013","article-title":"Pancreas and pancreas-kidney transplantation.","volume":"7","author":"Sutherland","year":"1998","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R171-20260521","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.hpb.2018.07.018","article-title":"A comparison of portal venous versus systemic venous drainage in pancreas transplantation.","volume":"21","author":"Siskind","year":"2019","journal-title":"HPB"},{"key":"R172-20260521","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1097\/00007890-200004150-00051","article-title":"Low incidence of kidney rejection after simultaneous kidney-pancreas transplantation after antithymocyte globulin induction and in the absence of corticosteroids: results of a prospective pilot study in 28 consecutive cases.","volume":"69","author":"Cantarovich","year":"2000","journal-title":"Transplantation"},{"key":"R173-20260521","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archsurg.138.10.1121","article-title":"Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation.","volume":"138","author":"Freise","year":"2003","journal-title":"Arch Surg"},{"key":"R174-20260521","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/j.1600-6143.2008.02373.x","article-title":"Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation.","volume":"8","author":"Muthusamy","year":"2008","journal-title":"Am J Transplant"},{"key":"R175-20260521","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1600-6143.2005.00816.x","article-title":"Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation.","volume":"5","author":"Cantarovich","year":"2005","journal-title":"Am J Transplant"},{"key":"R176-20260521","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.tp.0000287117.98785.54","article-title":"Steroid-free maintenance immunosuppression with rapamune and low-dose neoral in pancreas transplant recipients.","volume":"84","author":"Rajab","year":"2007","journal-title":"Transplantation"},{"key":"R177-20260521","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1399-0012.2006.00521.x","article-title":"Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression.","volume":"20","author":"Rajab","year":"2006","journal-title":"Clin Transplant"},{"key":"R178-20260521","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/TP.0b013e3181c9dc9b","article-title":"Comparing an early corticosteroid\/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.","volume":"89","author":"Knight","year":"2010","journal-title":"Transplantation"},{"key":"R179-20260521","doi-asserted-by":"crossref","first-page":"e15063","DOI":"10.1111\/ctr.15063","article-title":"Impact of early corticosteroid withdrawal on simultaneous pancreas-kidney transplant long-term outcomes: single center experience and comparison to the International Pancreas Transplant Registry.","volume":"37","author":"Pierce","year":"2023","journal-title":"Clin Transplant"},{"key":"R180-20260521","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/TP.0000000000004295","article-title":"Recipient and graft outcomes in simultaneous kidney and pancreas transplantation with steroid avoidance in the United States.","volume":"107","author":"Cerise","year":"2023","journal-title":"Transplantation"},{"key":"R181-20260521","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1600-6143.2005.01166.x","article-title":"Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction\u2014long-term results.","volume":"6","author":"Kaufman","year":"2006","journal-title":"Am J Transplant"},{"key":"R182-20260521","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/TXD.0000000000000634","article-title":"Alemtuzumab induction and delayed acute rejection in steroid-free simultaneous pancreas-kidney transplant recipients.","volume":"3","author":"Bank","year":"2016","journal-title":"Transplant Direct"},{"key":"R183-20260521","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1111\/ajt.14921","article-title":"Steroid-free three-drug maintenance regimen for pancreas transplant alone: comparison of induction with rabbit antithymocyte globulin\u00b1rituximab.","volume":"18","author":"Fridell","year":"2018","journal-title":"Am J Transplant"},{"key":"R184-20260521","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1016\/j.ajt.2025.01.021","article-title":"OPTN\/SRTR 2023 annual data report: pancreas.","volume":"25","author":"Kandaswamy","year":"2025","journal-title":"Am J Transplant"},{"key":"R185-20260521","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/lt.21396","article-title":"Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials.","volume":"14","author":"Segev","year":"2008","journal-title":"Liver Transpl"},{"key":"R186-20260521","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1432-2277.2009.00893.x","article-title":"Corticosteroid-free immunosuppression in liver transplantation: a meta-analysis and meta-regression of outcomes.","volume":"22","author":"Sgourakis","year":"2009","journal-title":"Transpl Int"},{"key":"R187-20260521","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.3748\/wjg.v20.i31.10703","article-title":"Corticosteroid-free immunosuppression in liver transplantation: an evidence-based review.","volume":"20","author":"Sgourakis","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R188-20260521","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12072-014-9523-y","article-title":"Role of steroid minimization in the tacrolimus-based immunosuppressive regimen for liver transplant recipients: a systematic review and meta-analysis of prospective randomized controlled trials.","volume":"8","author":"Gu","year":"2014","journal-title":"Hepatol Int"},{"key":"R189-20260521","doi-asserted-by":"crossref","first-page":"12330","DOI":"10.3748\/wjg.v20.i34.12330","article-title":"Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis.","volume":"20","author":"Lan","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R190-20260521","first-page":"CD007606","article-title":"Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.","volume":"4","author":"Fairfield","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R191-20260521","first-page":"CD007606","article-title":"Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.","volume":"12","author":"Fairfield","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R192-20260521","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.hpb.2020.09.012","article-title":"Randomized trial of steroid free immunosuppression with basiliximab induction in adult live donor liver transplantation (LDLT).","volume":"23","author":"Kathirvel","year":"2021","journal-title":"HPB (Oxford)"},{"key":"R193-20260521","doi-asserted-by":"crossref","first-page":"604","DOI":"10.5009\/gnl15017","article-title":"Efficacy and safety of a steroid-free immunosuppressive regimen after liver transplantation for hepatocellular carcinoma.","volume":"10","author":"Wei","year":"2016","journal-title":"Gut Liver"},{"key":"R194-20260521","doi-asserted-by":"crossref","first-page":"e1488","DOI":"10.1097\/TXD.0000000000001488","article-title":"Steroid avoidance after adult living donor liver transplant: a cohort analysis.","volume":"9","author":"Nunez","year":"2023","journal-title":"Transplant Direct"},{"key":"R195-20260521","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/00365521.2018.1463390","article-title":"Steroid-free immunosuppression with low-dose tacrolimus is safe and significantly reduces the incidence of new-onset diabetes mellitus following liver transplantation.","volume":"53","author":"Castedal","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"R196-20260521","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1751-2980.12008","article-title":"Safety and efficacy of four steroid-minimization protocols in liver transplant recipients: 3-year follow-up in a single center.","volume":"14","author":"Hu","year":"2013","journal-title":"J Dig Dis"},{"key":"R197-20260521","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/hep.1840210107","article-title":"Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation.","volume":"21","author":"Sheiner","year":"1995","journal-title":"Hepatology"},{"issue":"4 Suppl 1","key":"R198-20260521","first-page":"S107","article-title":"Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.","volume":"5","author":"Charlton","year":"1999","journal-title":"Liver Transplant Surg"},{"key":"R199-20260521","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1196\/annals.1423.046","article-title":"Impact of steroids on hepatitis C virus replication in vivo and in vitro.","volume":"1110","author":"Henry","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R200-20260521","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1097\/TP.0000000000002916","article-title":"Incidence and risks for nonalcoholic fatty liver disease and steatohepatitis post-liver transplant: systematic review and meta-analysis.","volume":"103","author":"Saeed","year":"2019","journal-title":"Transplantation"},{"key":"R201-20260521","doi-asserted-by":"crossref","first-page":"24","DOI":"10.21037\/tgh.2019.10.12","article-title":"Nonalcoholic steatohepatitis recurrence after liver transplant.","volume":"5","author":"Taneja","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"key":"R202-20260521","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jceh.2023.03.013","article-title":"NASH after liver transplantation: impact of immunosuppression.","volume":"13","author":"Taneja","year":"2023","journal-title":"J Clin Exp Hepatol"},{"key":"R203-20260521","first-page":"e7569","article-title":"Prevalence and risk factors for obesity after liver transplantation: a single-center experience.","volume":"13","author":"Akarsu","year":"2013","journal-title":"Hepat Mon"},{"key":"R204-20260521","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/lt.25657","article-title":"Nonalcoholic steatohepatitis after liver transplantation.","volume":"26","author":"Cotter","year":"2020","journal-title":"Liver Transpl"},{"key":"R205-20260521","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/TP.0000000000001709","article-title":"Long-term outcomes in patients undergoing liver transplantation for nonalcoholic steatohepatitis-related cirrhosis.","volume":"101","author":"Bhati","year":"2017","journal-title":"Transplantation"},{"key":"R206-20260521","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/lt.25205","article-title":"Con: steroids should not be withdrawn in transplant recipients with autoimmune hepatitis.","volume":"24","author":"Theocharidou","year":"2018","journal-title":"Liver Transpl"},{"key":"R207-20260521","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/lt.25206","article-title":"Pro: Steroids can be withdrawn after transplant in recipients with autoimmune hepatitis.","volume":"24","author":"Kalra","year":"2018","journal-title":"Liver Transpl"},{"key":"R208-20260521","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/TP.0000000000002147","article-title":"International Liver Transplantation Society Consensus Statement on immunosuppression in liver transplant recipients.","volume":"102","author":"Charlton","year":"2018","journal-title":"Transplantation"},{"key":"R209-20260521","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/LVT.0000000000000419","article-title":"Recurrence of autoimmune liver diseases after liver transplantation: review and expert opinion statement.","volume":"31","author":"Montano-Loza","year":"2025","journal-title":"Liver Transpl"},{"key":"R210-20260521","doi-asserted-by":"crossref","first-page":"2230871","DOI":"10.1080\/07853890.2023.2230871","article-title":"Risk factors for fractures following liver transplantation: a population-based cohort study.","volume":"55","author":"Chang","year":"2023","journal-title":"Ann Med"},{"key":"R211-20260521","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/S0140-6736(03)15104-5","article-title":"Steroid-free liver transplantation in children.","volume":"362","author":"Reding","year":"2003","journal-title":"Lancet"},{"key":"R212-20260521","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1097\/01.TP.0000063938.49112.C2","article-title":"Steroid withdrawal after pediatric liver transplantation: a long-term follow-up study in 109 recipients.","volume":"75","author":"Diem","year":"2003","journal-title":"Transplantation"},{"key":"R213-20260521","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/lt.21397","article-title":"Steroid-free, tacrolimus-basiliximab immunosuppression in pediatric liver transplantation: clinical and pharmacoeconomic study in 50 children.","volume":"14","author":"Gras","year":"2008","journal-title":"Liver Transpl"},{"key":"R214-20260521","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/LVT.0000000000000255","article-title":"Early steroids after pediatric liver transplantation protect against T-cell-mediated rejection: results from the ChilSFree study.","volume":"30","author":"Goldschmidt","year":"2024","journal-title":"Liver Transpl"},{"key":"R215-20260521","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1600-6143.2009.02634.x","article-title":"Linear growth patterns in prepubertal children following liver transplantation.","volume":"9","author":"Alonso","year":"2009","journal-title":"Am J Transplant"},{"key":"R216-20260521","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/j.1600-6143.2006.01406.x","article-title":"Randomized trial of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression.","volume":"6","author":"Spada","year":"2006","journal-title":"Am J Transplant"},{"key":"R217-20260521","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/TP.0000000000004951","article-title":"Basiliximab induction and postoperative steroid-free immunosuppression with tacrolimus in pediatric liver transplantation: a randomized clinical trial.","volume":"108","author":"Dong","year":"2024","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T17:01:18Z","timestamp":1779382878000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":217,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005572","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]}}}